Topotecan in Treating Patients With Recurrent Brain Tumors

NCT00003372 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: topotecan hydrochloride

Sponsor

NCIC Clinical Trials Group